Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | TMPRSS6 | Q8IU80 | 1/20 | 0.50 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.50 |
| ▸ | PEPD | P12955 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL399197 | 0.92 | KIF11 (0.48) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL447770 | 0.89 | PEPD (0.60) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL6880468 | 0.89 | F2 (0.43) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL1438380 | 0.89 | MAPT (0.56) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL166139 | 0.87 | KIF11 (0.55) | NPC1CYP3A4CYP2C19MAPTRAB9A | |
| SCHEMBL10815124 | 0.87 | PRSS1 (0.69) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL4029597 | 0.87 | ALDH1A1 (0.61) | F2PRSS1PRSS2PRSS3ST14 | |
| SCHEMBL1184889 | 0.87 | SIGMAR1 (0.53) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL348736 | 0.87 | F2 (0.42) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| Hydrochloric Acid SCHEMBL10495490 | 0.87 | MAPT (0.54) | F2PRSS1PRSS2PRSS3TMPRSS6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020218835-A1 | NOVEL POLYIMIDE-TYPE POLYMER AND PREPARATION METHOD THEREFOR | 서울대학교 산학협력단 | 2020-10-29 | — | — | WO | claimed |
| CN-118749016-A | Thermoplastic resin composition for hot melt lamination molding, molded body, and method for producing the same | 株式会社ADEKA | 2024-10-08 | — | — | CN | disclosed |
| CN-117143396-A | Particulate ultraviolet absorber and resin composition | 株式会社艾迪科 | 2023-12-01 | — | — | CN | disclosed |
| CN-117143033-A | Particulate ultraviolet absorber and resin composition | 株式会社艾迪科 | 2023-12-01 | — | — | CN | disclosed |
| CN-117143395-A | Particulate ultraviolet absorber and resin composition | 株式会社艾迪科 | 2023-12-01 | — | — | CN | disclosed |
| US-11779583-B2 | Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction | EMORY UNIVERSITY (US) | 2023-10-10 | — | — | US | disclosed |
| CN-116813979-A | Nucleating agent, synthetic resin composition containing same, and molded article thereof | 株式会社ADEKA | 2023-09-29 | — | — | CN | disclosed |
| CN-112004905-B | Particulate ultraviolet absorber and resin composition | 株式会社艾迪科 | 2023-08-22 | — | — | CN | disclosed |
| CN-112105704-B | Particulate ultraviolet absorber and resin composition | 株式会社艾迪科 | 2023-08-22 | — | — | CN | disclosed |
| CN-111936594-B | Particulate ultraviolet absorber and resin composition | 株式会社艾迪科 | 2023-08-18 | — | — | CN | disclosed |
| US-20040104377-A1 | Non-toxic corrosion-protection pigments based on rare earth elements | UNIVERSITY OF DAYTON | 2004-06-03 | — | — | US | disclosed |
| US-20040020568-A1 | Non-toxic corrosion-protection conversion coats based on rare earth elements | DAYTON, UNIVERSITY OF | 2004-02-05 | — | — | US | disclosed |
| US-20040016363-A1 | CORROSION-INHIBITING COATING | VENTURE LENDING & LEASING, IV, INC. | 2004-01-29 | — | — | US | disclosed |
| WO-2004009869-A2 | CORROSION-INHIBITING COATING FOR METAL SURFACES | UNIVERSITY OF DAYTON (US) | 2004-01-29 | — | — | WO | disclosed |
| US-20040016910-A1 | Non-toxic corrosion-protection rinses and seals based on rare earth elements | DAYTON, UNIVERSITY OF | 2004-01-29 | — | — | US | disclosed |
| US-20040011252-A1 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON | 2004-01-22 | — | — | US | disclosed |
| US-20030234063-A1 | Non-toxic corrosion-protection conversion coats based on cobalt | DAYTON, UNIVERSITY OF | 2003-12-25 | — | — | US | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779583-B2 | Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction | SHBG, ABAT, GLS | F2 867/4885PRSS1 1088/4885PRSS2 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.